Key points are not available for this paper at this time.
The role of gastrin-releasing peptide receptor (GRPR) in various diseases, including cancer, has been extensively studied and has emerged as a promising therapeutic target. In this study, we successfully achieved the use of [
Saidi et al. (Thu,) studied this question.